Lv01
0 积分 2021-12-30 加入
Current and emerging therapies for autoimmune encephalitis
1小时前
已完结
Complement and cytokine based therapeutic strategies in myasthenia gravis
3个月前
已完结
B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling
3个月前
已完结
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential
3个月前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
3个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3个月前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
4个月前
已完结
THE TEN-YEAR MORTALITY IN BEHÇET'S SYNDROME
5个月前
已完结
Clinical manifestations of Behçet’s disease in a large cohort of Chinese patients: gender- and age-related differences
5个月前
已完结
Systemic Lupus Erythematosus Disease Activity Score Remission and Low Disease Activity States Discriminate Drug From Placebo and Better Health‐Related Quality of Life
6个月前
已完结
皖公网安备34019202002308
